Sign in Register

Drug class

Drugs to Treat Alcoholism

The phrase "drugs to treat alcoholism" is a broad therapeutic functional grouping rather than a single pharmacologic class with a unified mechanism of action. Read more about Drugs to Treat Alcoholism

32 drugs in this class 28 manufacturers

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs Alcohol Use DisorderTop indication · 48 prescription drugs

Showing 19–27 of 32 drugs

Sort

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

PROFICIENT RX L

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

BRYANT RANCH PR

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

AHP

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

SpecGx

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

Avet Pharmaceuticals

DISULFIRAM

ALCOHOL-SENSITIZING AGENTS · ALCOHOL USE DISORDER

Hikma Pharmaceuticals USA

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

APHENA PHARMA S

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

ELITE LABORATOR

NALTREXONE HCL

OPIOID ANTAGONISTS · ALCOHOL USE DISORDER ·+1

GSMS, INC.

Filter & compare in the drug finder → Opens the drug finder with Drugs to Treat Alcoholism preselected. Add indication or manufacturer filters there.

About Drugs to Treat Alcoholism.

The phrase "drugs to treat alcoholism" is a broad therapeutic functional grouping rather than a single pharmacologic class with a unified mechanism of action.

In clinical practice and regulatory contexts, it designates pharmacotherapies indicated as adjuncts to psychosocial support for managing alcohol use disorder (historically referred to as alcoholism or alcohol dependence).

Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosate modulates glutamatergic and GABAergic neurotransmission to alleviate post-cessation neurochemical imbalances.

nih.gov
The phrase "drugs to treat alcoholism" is a broad therapeutic functional grouping rather than a single pharmacologic class with a unified mechanism of action Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosate modulates glutamatergic and GABAergic neurotransmission to al...
fda.gov
The phrase "drugs to treat alcoholism" is a broad therapeutic functional grouping rather than a single pharmacologic class with a unified mechanism of action In clinical practice and regulatory contexts, it designates pharmacotherapies indicated as adjuncts to psychosocial support for managing alcohol use disorder (historically referred to as alcoholism or alcohol dependence)
jcoinctc.org
In clinical practice and regulatory contexts, it designates pharmacotherapies indicated as adjuncts to psychosocial support for managing alcohol use disorder (historically referred to as alcoholism or alcohol dependence)
medlineplus.gov
In clinical practice and regulatory contexts, it designates pharmacotherapies indicated as adjuncts to psychosocial support for managing alcohol use disorder (historically referred to as alcoholism or alcohol dependence) Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosat...
drugfree.org
Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosate modulates glutamatergic and GABAergic neurotransmission to alleviate post-cessation neurochemical imbalances
nih.gov
Agents in this category act through distinct mechanisms to support abstinence or reduce heavy consumption: disulfiram induces an aversive reaction by inhibiting aldehyde dehydrogenase, naltrexone attenuates reinforcing reward pathways by blocking opioid receptors, and acamprosate modulates glutamatergic and GABAergic neurotransmission to alleviate post-cessation neurochemical imbalances